IL17A and Insulin resistance: Collectively, our data support a role for MAIT cells in the development of metabolic dysfunction, and suggest that an IL-17-mediated effect on intracellular insulin signalling may be involved in driving this dysfunction, potentially highlighting a novel therapeutic target for insulin resistance.